Latest Breaking News On - Jerome lipper multiple myeloma center - Page 18 : comparemela.com

New recommendations aim to eliminate racial bias in myeloma trials

New recommendations aim to eliminate racial bias in myeloma trials
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

United statesNicole gormleyLola fashoyinDana farber cancer institute kennethc andersonAmerican association for cancer researchJerome lipper multiple myeloma centerDrug administrationDana farber cancer instituteLebow institute for myeloma therapeuticsAmerican associationCancer researchAfrican americansBlood cancer discoveryAfrican americanLebow instituteMyeloma therapeutics

FDA Approves Selinexor Combination Treatment for Certain Patients With Multiple Myeloma

FDA Approves Selinexor Combination Treatment for Certain Patients With Multiple Myeloma
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelg kauffmanPaul richardsonSharon shachamSelective inhibitor of nuclear exportKaryopharm therapeutics incApproval programClinical researchClinical program leaderSelective inhibitorNuclear exportChief scientific officerIndependent review committeeJerome lipper multiple myeloma centerDana farber cancer instituteChief executive officer

Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy

Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
homenewshere.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from homenewshere.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelg kauffmanPaul richardsonSharon shachamSelective inhibitor of nuclear exportKaryopharm therapeutics incNational cancer instituteDrug administrationTakeda pharmaceutical companyExchange commissionApproval programEuropean unionKaryopharm selective inhibitor of nuclear exportEuropean medicines agencyClinical researchInformation department